Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolismKLIPPING, Christine; MARR, Joachim.Contraception (Stoneham). 2005, Vol 71, Num 6, pp 409-416, issn 0010-7824, 8 p.Article

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenKLIPPING, Christine; DUIJKERS, Ingrid; TRUMMER, Dietmar et al.Contraception (Stoneham). 2008, Vol 78, Num 1, pp 16-25, issn 0010-7824, 10 p.Article

Ethinyl estradiol 20 μg/drospirenone 3 mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorderMARR, Joachim; HEINEMANN, Klaas; KUNZ, Michael et al.International journal of gynaecology and obstetrics. 2011, Vol 113, Num 2, pp 103-107, issn 0020-7292, 5 p.Article

Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptiveANTTILA, Leena; KUNZ, Michael; MARR, Joachim et al.Contraception (Stoneham). 2009, Vol 80, Num 5, pp 445-451, issn 0010-7824, 7 p.Article

Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosisSTROWITZKI, Thomas; MARR, Joachim; GERLINGER, Christoph et al.International journal of gynaecology and obstetrics. 2012, Vol 117, Num 3, pp 228-233, issn 0020-7292, 6 p.Article

Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian womenANZAI, Yuzuru; HEGER-MAHN, Doris; SCHELLSCHMIDT, Ilka et al.Contraception (Stoneham). 2012, Vol 86, Num 1, pp 28-34, issn 0010-7824, 7 p.Article

Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimenMARR, Joachim; NIKNIAN, Minoo; SHULMAN, Lee P et al.Contraception (Stoneham). 2011, Vol 84, Num 1, pp 81-86, issn 0010-7824, 6 p.Article

Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysisKOLTUN, William; MALONEY, J. Michael; MARR, Joachim et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 155, Num 2, pp 171-175, issn 0301-2115, 5 p.Article

Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimenHEMADI, Laszló; MARR, Joachim; TRUMMER, Dietmar et al.Contraception (Stoneham). 2009, Vol 80, Num 1, pp 18-24, issn 0010-7824, 7 p.Article

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenoneBACHMANN, Gloria; SULAK, Patricia J; SAMPSON-LANDERS, Carole et al.Contraception (Stoneham). 2004, Vol 70, Num 3, pp 191-198, issn 0010-7824, 8 p.Article

A Combined Oral Contraceptive Containing 3-mg Drospirenone/ 20-μg Ethinyl Estradiol in the Treatment of Acne Vulgaris : A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessmentLUCKY, Anne W; KOLTUN, William; THIBOUTOT, Diane et al.Cutis (New York, NY). 2008, Vol 82, Num 2, pp 143-150, issn 0011-4162, 8 p.Article

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study populationGERLINGER, Christoph; TRUSSELL, James; MELLINGER, Uwe et al.Contraception (Stoneham). 2014, Vol 90, Num 2, pp 142-146, issn 0010-7824, 5 p.Article

Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter studyBART SR, Stephan; MARR, Joachim; DIEFENBACH, Konstanze et al.Contraception (Stoneham). 2012, Vol 85, Num 1, pp 42-50, issn 0010-7824, 9 p.Article

Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris : a randomized, double-blind, placebo-controlled trialKOLTUN, William; LUCKY, Anne W; THIBOUTOT, Diane et al.Contraception (Stoneham). 2008, Vol 77, Num 4, pp 249-256, issn 0010-7824, 8 p.Article

Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis of four open-label studiesANTTILA, Leena; BACHMANN, Gloria; HERNADI, László et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 155, Num 2, pp 180-182, issn 0301-2115, 3 p.Article